Analyst Ratings for Faeth Therapeutics (FTH)
FTH Rating Summary
FTH Price Target Summary
- Highest: $70.00 (Guggenheim)
- Lowest: $51.00 (Citizens)
- Average: $58.22
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$58.22 (+107.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/15/2026 | Guggenheim | Brad Canino | New Coverage | Buy (N/A) |
70.00 (N/A) |
39.09 (28.00) |
-28.37% | Details |
| 9/14/2026 | Lucid Capital Markets | Dev Prasad | New Coverage | Buy (N/A) |
59.00 (N/A) |
37.44 (28.00) |
-25.21% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
